Michael W. Nicolle, MD ABSTRACT Purpose of Review: This article discusses the pathogenesis, diagnosis, and management of autoimmune myasthenia gravis (MG) and Lambert-Eaton

HISTORICAL NOTE Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert’s pioneering article Síndrome miastênica de Lambert-Eaton:

Udaya Seneviratne, Rajith de Silva Summary The Lambert-Eaton myasthenic syndrome is a neuromuscular dis- order characterised by defective neurotransmitter release at auto-

Article Non-paraneoplastic Lambert- Eaton myasthenic syndrome A brief review of 10 cases Paulo J. Lorenzoni, Rosana H. Scola, Cláudia S. Kamoi Kay, Sérgio F.

3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials3,4-diaminopyridine treatment for Lambert- Eaton

698-701_Wirtz_JON-1063J Neurol (2003) 250 : 698–701 DOI 10.1007/s00415-003-1063-7 ORIGINAL COMMUNICATION Paul W. Wirtz Marianne G. Nijnuis Mohammad Sotodeh Luc N. A.

Introduction Myasthenia gravis (MG) and Lambert-Eaton myasthenic syn- drome (LEMS) are two distinct autoimmune disorders that affect neuromuscular transmission. MG is a postsynaptic

Clinical presentation and differential diagnosis of Lambert-Eaton myasthenic syndromeClinical presentation and differential diagnosis of Lambert-Eaton myasthenic syndrome

jopj0jjjopjjopjjjpoDOI: 10.5505/ejm.2019.58855 *Corresponding Author: Fettah Eren, University of Health Sciences, Konya Training and Research Hospital, Clinic of Neurology,

CASE REPORT Lambert-Eaton myasthenic syndrome (LEMS) is an antibody- mediated disorder of the neuromuscular junction that is most com- monly diagnosed in association with